Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Eptacog Beta Efficacy in Treating Mild or Moderate Bleeds in Target Joints of Individuals with Hemophilia A or B and Inhibitors in PERSEPT 1

Blood (2022) 140 (Supplement 1): 5597–5599.

https://doi.org/10.1182/blood-2022-156110

Published: 2022

Journal Articles

Novel Gamma-Glutamyl Carboxylase Mutation Causing Hemorrhagic and Non-Hemorrhagic VKCFD1 Phenotypes

Gianna M. Guzzardo, Suvoshree Ghosh, Behnaz Pezeshkpoor, Anna Pavlova, Katrin Czogalla-Nitsche, Johannes Oldenburg, Meera B. Chitlur

Blood (2022) 140 (Supplement 1): 8480–8482.

https://doi.org/10.1182/blood-2022-169105

Published: 2022

Journal Articles

Prevention of Bleeding in Patients with Moderate and Severe Hemophilia A Playing Sports: A Comparison between Factor VIII and Emicizumab Prophylaxis (STEP: SporTs Emicizumab Prophylaxis)

Meera B. Chitlur

Blood (2022) 140 (Supplement 1): 5619–5620.

https://doi.org/10.1182/blood-2022-165183

Published: 2022

Journal Articles

Adolescents and Young Adults with Immune Thrombocytopenia (ITP): A Project of the Carmen-France and Parc-ITP Registry

Alexandra Schifferli, Guillaume Moulis, Bertrand Godeau, Thierry Leblanc, Marc Michel, Nathalie Aladjidi, Guy Leverger, Mohsen Saleh Elalfy, John Grainger, Meera B. Chitlur, Andrea Heiri, Susanne Holzhauer, Thomas Kuehne

Blood (2021) 138 (Supplement 1): 2079.

https://doi.org/10.1182/blood-2021-148488

Published: 2021

Journal Articles

Ex Vivo Evaluation of Red Blood Cell Adhesion and Whole Blood Thrombosis in Pyruvate Kinase Deficiency

Patrick C. Hines, Xiufeng Gao, Andrew Herppich, Wendy Hollon, Meera B. Chitlur, Janet L. Kwiatkowski, Michael Tarasev

Blood (2021) 138 (Supplement 1): 923.

https://doi.org/10.1182/blood-2021-149744

Published: 2021

Journal Articles

Evaluation of Coagulation and Inflammatory Markers in Pediatric Patients on Extracorporeal Membrane Oxygenation (ECMO)

Katherine Regling, DO, Katherine Cashen, DO, Manisha Gadgeel, MBBS, MS, Yue Xi, PhD, Andrew Herppich, Michael Tarasev, Patrick C. Hines, MDPhD, Meera B. Chitlur, MD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-140900

Published: 2020

Journal Articles

Inhibit Clinical Trials Platform to Prevent and Eradicate Inhibitors: Feasibility Survey of Current Prophylaxis and Immune Tolerance Practices

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-136814

Published: 2020

Journal Articles

Factor XII Deficiency in ECMO Patients

Katherine Regling, DO, Sarah Ramiz, MD, Meera B. Chitlur, MD

Blood (2019) 134 (Supplement_1): 4965.

https://doi.org/10.1182/blood-2019-131614

Published: 2019

Journal Articles

An Update on rFVIIa Use in Females with Rare Bleeding Disorders

Meera B. Chitlur, MD, Manuel Carcao, David Cooper, Shilpa Jain, Kaan Kavakli, Bryce Kerlin, Skye Peltier, Man-Chiu Poon, Hossam Saad, Amy Shapiro

Blood (2019) 134 (Supplement_1): 1119.

https://doi.org/10.1182/blood-2019-130298

Published: 2019

Journal Articles

On the Role of F8 Sequence Mismatch and Class-II Human Leukocyte Antigen Binding in the Development of Neutralizing Antibodies ("Inhibitors") Directed Against Therapeutic Factor VIII Proteins (tFVIIIs): Evidence from the PATH Study

Vincent P. Diego, PhD, Bernadette W. Luu, B.S., M.T. (CLS), Afshin Ameri, MD, Meera B. Chitlur, MD, Marcio A. Almeida, PhD, Karin Haack, PhD, Satish Kumar, PhD, Long V. Dinh, PhD, Henry Mead, M.B.A., M.P.H., Jerry S. Powell, MD, Miguel A. Escobar, MD, Raja Rajalingam, PhD, Sarah Williams-Blangero, PhD, Carol K. Kasper, MD, Laura Almasy, PhD, Shelley Cole, PhD, John Blangero, PhD, Tom E. Howard, MD, PhD

Blood (2019) 134 (Supplement_1): 2393.

https://doi.org/10.1182/blood-2019-132218

Published: 2019

Journal Articles

RUNX1 associated Familial Platelet Disorder with Myeloid Malignancy (FPD-MM) in Children: A Novel New Phenotype with Juvenile and Chronic Myelomonocytic Leukemia (JMML/CMML) Characteristics

Katherine Regling, DO, Shruti Bagla, PhD, Ahmar Urooj Zaidi, MD BSc, Erin Wakeling, PhD, Michael C. Chicka, PhD, Leigh Flores, MD, Manisha Gadgeel, MBBS, MS, Steven Buck, MS, Meera B. Chitlur, MD, Charles A. Schiffer, MD, Yaddanapudi Ravindranath, MBBS

Blood (2018) 132 (Supplement 1): 5504.

https://doi.org/10.1182/blood-2018-99-116925

Published: 2018

Journal Articles

Genetics of Factor VIII Inhibitor Development in Hemophilia Patients: Novel Statistical Approaches in the PATH Study

Vincent P. Diego, PhD, Marcio A. Almeida, PhD, Bernadette W. Luu, BS, MT/CLS, Karin Haack, PhD, Meera B. Chitlur, MD, Afshin Ameri, MD, Long V. Dinh, PhD, Raja Rajalingam, PhD, Jerry S. Powell, MD, John Blangero, PhD, Laura Almasy, PhD, Shelley Cole, PhD, Tom E. Howard

Blood (2018) 132 (Supplement 1): 1199.

https://doi.org/10.1182/blood-2018-99-120021

Published: 2018

Journal Articles

Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)

Pratima Chowdary, MD, Lone Hvitfeldt Poulsen, Miguel A Escobar, MD, Susan Kearney, Meera B. Chitlur, MD, Robert Klamroth, Mudi Misgav, Claude Negrier, Wan Hui Ong Clausen, Frank Driessler, Andrea Landorph, Elena Santagostino

Blood (2018) 132 (Supplement 1): 1177.

https://doi.org/10.1182/blood-2018-99-110308

Published: 2018

Journal Articles

Utility of Thromboelastography for the Diagnosis of Von Willebrand Disease

Katherine Regling, D.O., Srikruthi Kakulavarapu, MD, Ronald Thomas, PhD, Wendy Hollon, M.T., Meera B. Chitlur, MD

Blood (2016) 128 (22): 3788.

https://doi.org/10.1182/blood.V128.22.3788.3788

Published: 2016

Journal Articles

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Natasha Amrita Satkunam, MBBS, MSc, Johnny Mahlangu, MD, Christoph Bidlingmaier, MD PD, Dr. MD, Maria Eva Mingot-Castellano, PhD, Meera B. Chitlur, MD, Patrick F. Fogarty, MD, Adam Cuker, MD MS, Maria Elisa Mancuso, MD PhD, Pal André Holme, PhD MD, Julie Grabell, BA, CCRP, Wilma Hopman, MA, Prasad Mathew, MD, Paula D. James, MD

Blood (2016) 128 (22): 875.

https://doi.org/10.1182/blood.V128.22.875.875

Published: 2016

Journal Articles

Thrombelastography (TEG) and Thrombin Generation Assay (TGA) in Severe Hemophilia Following Factor Replacement Therapy

Tania T. Sarker, MD MPH, Donald Brophy, Meera B. Chitlur, MD

Blood (2015) 126 (23): 4666.

https://doi.org/10.1182/blood.V126.23.4666.4666

Published: 2015

Journal Articles

Impact of Glanzmann’s Thrombasthenia (GT): Perceptions from US Patients and Parents

Michael Recht, MD PhD, Madhvi Rajpurkar, MD, Meera B. Chitlur, MD, Mark Reding, Mary Jane Frey, RN, BSN, CPN, Skye Peltier, MPH, PA-C, Christine Guelcher, MS, PNP-BC, Dana Stephens, RN, MS, CPNP, David L. Cooper, MD MBA

Blood (2014) 124 (21): 4853.

https://doi.org/10.1182/blood.V124.21.4853.4853

Published: 2014

Journal Articles

Unmet Needs in Diagnosis and Treatment of Glanzmann’s Thrombasthenia (GT): Perceptions of US Hematologists and Nurses

Meera B. Chitlur, MD, Michael Recht, MD PhD, Madhvi Rajpurkar, MD, Ellis J. Neufeld, MD PhD, Craig M. Kessler, MD, Mark Reding, Michael Tarantino, MD, David L. Cooper, MD MBA

Blood (2014) 124 (21): 2179.

https://doi.org/10.1182/blood.V124.21.2179.2179

Published: 2014

Journal Articles

Thromboelastography for Monitoring of Hemostatic Changes Following Factor Administration

Meera B. Chitlur, MD, Latha B. Rao, MD, Michael Callaghan, MD, Madhvi Rajpurkar, MD, Jeanne M. Lusher, MD

Blood (2012) 120 (21): 3373.

https://doi.org/10.1182/blood.V120.21.3373.3373

Published: 2012

Journal Articles

Toward Prediction of Thrombosis in Adolescent Girls On Estrogen Containing Contraceptives: Global Coagulation Profiles and Estrogen Gene Polymorphisms.

Ayesha N. Zia, MD, Michael U Callaghan, MD, Anju Sawni, MD, Alcesa Backos, MD, Latha Rao, MD, Meera B. Chitlur, MD, Jeanne M. Lusher, MD, Madhvi Rajpurkar, MD

Blood (2012) 120 (21): 2254.

https://doi.org/10.1182/blood.V120.21.2254.2254

Published: 2012

NARROW

Eptacog Beta Efficacy in Treating Mild or Moderate Bleeds in Target Joints of Individuals with Hemophilia A or B and Inhibitors in PERSEPT 1

Novel Gamma-Glutamyl Carboxylase Mutation Causing Hemorrhagic and Non-Hemorrhagic VKCFD1 Phenotypes

Prevention of Bleeding in Patients with Moderate and Severe Hemophilia A Playing Sports: A Comparison between Factor VIII and Emicizumab Prophylaxis (STEP: SporTs Emicizumab Prophylaxis)

Adolescents and Young Adults with Immune Thrombocytopenia (ITP): A Project of the Carmen-France and Parc-ITP Registry

Ex Vivo Evaluation of Red Blood Cell Adhesion and Whole Blood Thrombosis in Pyruvate Kinase Deficiency

Evaluation of Coagulation and Inflammatory Markers in Pediatric Patients on Extracorporeal Membrane Oxygenation (ECMO)

Inhibit Clinical Trials Platform to Prevent and Eradicate Inhibitors: Feasibility Survey of Current Prophylaxis and Immune Tolerance Practices

Factor XII Deficiency in ECMO Patients

An Update on rFVIIa Use in Females with Rare Bleeding Disorders

On the Role of F8 Sequence Mismatch and Class-II Human Leukocyte Antigen Binding in the Development of Neutralizing Antibodies ("Inhibitors") Directed Against Therapeutic Factor VIII Proteins (tFVIIIs): Evidence from the PATH Study

RUNX1 associated Familial Platelet Disorder with Myeloid Malignancy (FPD-MM) in Children: A Novel New Phenotype with Juvenile and Chronic Myelomonocytic Leukemia (JMML/CMML) Characteristics

Genetics of Factor VIII Inhibitor Development in Hemophilia Patients: Novel Statistical Approaches in the PATH Study

Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)

Utility of Thromboelastography for the Diagnosis of Von Willebrand Disease

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Thrombelastography (TEG) and Thrombin Generation Assay (TGA) in Severe Hemophilia Following Factor Replacement Therapy

Impact of Glanzmann’s Thrombasthenia (GT): Perceptions from US Patients and Parents

Unmet Needs in Diagnosis and Treatment of Glanzmann’s Thrombasthenia (GT): Perceptions of US Hematologists and Nurses

Thromboelastography for Monitoring of Hemostatic Changes Following Factor Administration

Toward Prediction of Thrombosis in Adolescent Girls On Estrogen Containing Contraceptives: Global Coagulation Profiles and Estrogen Gene Polymorphisms.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only